In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...

To secure Cassidy’s decisive confirmation vote, Kennedy committed to maintaining the Centers for Disease Control and ...

The changes are the latest move by the federal health department, led by Robert F. Kennedy Jr., to sow doubt about childhood ...

If Moore’s law applies to life expectancy the way it does to electronics, then we’ll have to spend and innovate exponentially ...

The new report reveals that many of the authors and reviewers have been outspoken critics of gender-affirming care and belong ...

In this week's STATus Report video, an inside look at RFK Jr.'s first nine months atop HHS, from his management style and ...

Abbott is buying Exact Sciences, the maker of tests designed to detect early cancers, in a $21 billion deal, a sign of ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

Function Health's $300 million fundraise, K Health's primary care play, new AI startup from Berkeley, and more.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Lots more details about the fallout from STAT’s John Wilkerson. Read more here.

Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.